BioNTech SE (BNTX) Total Liabilities (2018 - 2025)
BioNTech SE (BNTX) posted Total Liabilities of $3.2 billion for Q4 2025, down 3.88% sequentially from $3.3 billion in Q3 2025, and down 3.44% YoY from $3.3 billion in Q4 2024.
BioNTech SE (BNTX) Total Liabilities (2018 - 2025) Analysis & Trends
BioNTech SE has reported Total Liabilities for 8 years, with the latest figure at $3.2 billion in Q4 2025.
- Quarterly Total Liabilities fell 3.44% year-over-year to $3.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 billion (down 3.44% YoY) and the FY2025 annual result came in at $3.1 billion, down 6.28% from the prior year.
- Total Liabilities slipped to $3.2 billion in Q4 2025 per BNTX's latest filing, from $3.3 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $6.5 billion in Q3 2021 and troughed at $7.0 million in Q4 2021.
- A 5-year average of $3.3 billion and a median of $3.3 billion in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Liabilities plunged 99.38% in 2021, then jumped 47029.01% in 2022.
- Over 5 years, Total Liabilities stood at $7.0 million in 2021, then surged by 47029.01% to $3.3 billion in 2022, then fell by 9.69% to $3.0 billion in 2023, then gained by 12.21% to $3.3 billion in 2024, then slipped by 3.44% to $3.2 billion in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $3.2 billion, $3.3 billion, and $3.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 3.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.22 Bn |
| Sep 30, 2025 | 3.35 Bn |
| Jun 30, 2025 | 3.55 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 3.33 Bn |
| Sep 30, 2024 | 3.61 Bn |
| Jun 30, 2024 | 3.41 Bn |
| Mar 31, 2024 | 2.49 Bn |
| Dec 31, 2023 | 2.97 Bn |
| Sep 30, 2023 | 2.55 Bn |
| Jun 30, 2023 | 2.53 Bn |
| Mar 31, 2023 | 1.95 Bn |
| Dec 31, 2022 | 3.29 Bn |
| Sep 30, 2022 | 4.33 Bn |
| Jun 30, 2022 | 4.61 Bn |
| Mar 31, 2022 | 4.93 Bn |
| Dec 31, 2021 | 6.98 Mn |
| Sep 30, 2021 | 6.51 Bn |
| Jun 30, 2021 | 4.41 Bn |
| Mar 31, 2021 | 2.03 Bn |